Benzinga | Aug 5, 2021 05:56PM EDT

Exelixis Q2 Adj. EPS $0.37 Beats $0.07 Estimate, Sales $385.18M Beat $298.16M Estimate; Raises FY21 Sales Guidance To $1.3B-$1.4B vs $1.23B Est.

Exelixis (NASDAQ:EXEL) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.07 by 428.57 percent. This is a 48 percent increase over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $385.18 million which beat the analyst consensus estimate of $298.16 million by 29.18 percent. This is a 48.44 percent increase over sales of $259.48 million the same period last year.